Current management options in hereditary haemorrhagic telangectasia

Rate this item
(0 votes)

Introduction: Hereditary haemorrhagic telangiectasia is an autosomal dominant vascular disease characterized by recurrent epistaxis, mucocutaneous telangiectasia and visceral arteriovenous malformations.

Methods: The genetic basis and pathophysiology of the disease are discussed. Diagnostic criteria and the clinical course of the condition are considered. The current management options, both medical and surgical, are reviewed.

Conclusion: Hereditary haemorrhagic telangiectasia requires specialist treatment for the problems it causes, and is best managed in specialist centres. Epistaxis is often the major symptom, significantly affecting patients’ quality of life and general well being. An understanding of the available treatment options is therefore important for the otorhinolaryngologist.

Additional Info

  • Authors: Joanne Rimmer & Valerie J Lund
  • Keywords: Epistaxis, Hereditary haemorrhagic telangiectasia, Osler-weber-rendu syndrome, HHT.
Read 6689 times Last modified on Thursday, 14 May 2020 14:44

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.


Member Login

          Forgot login? | Register

BBC News Feed

Get in touch

+44 207 637 3544

This email address is being protected from spambots. You need JavaScript enabled to view it.

The Otorhinolaryngologist,
73 Newman Street, London
W1T 3EJ, 


Rila Publications Ltd Ethics Policy